Accolade: Q3 Earnings Insights
Accolade (NASDAQ:ACCD) reported its Q3 earnings results on Monday, January 8, 2024 at 04:05 PM. Here’s what investors…
Earnings Scheduled For January 8, 2024
Companies Reporting Before The Bell
• Helen Of Troy (NASDAQ:HELE) is likely to report quarterly earnings at $2.75 per share on revenue of $544.39 million.
A Preview Of Accolade’s Earnings
Accolade (NASDAQ:ACCD) is set to give its latest quarterly earnings report on Monday, 2024-01-08. Here’s what investors need…
Cathie Wood’s Ark Invest Trims Bitcoin Exposure, Sells $2.9M Worth Of GBTC Shares Amid Crypto Market Volatility
On Thursday, Cathie Wood-led Ark Invest made a significant move by selling nearly $2.9 million worth of Grayscale Bitcoin Trust (OTC:GBTC) shares. This decision comes amidst a fluctuating crypto market and Ark’s strategic adjustments in their crypto holdings.
Expert Ratings for Accolade
Within the last quarter, Accolade (NASDAQ:ACCD) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…
Azenta Reports Upbeat Earnings, Joins Talis Biomedical, Sally Beauty And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded higher, with the Dow Jones gaining around 500 points on Tuesday.
Shares of Azenta, Inc. (NASDAQ: AZTA) rose on Tuesday after the company reported better-than-expected fourth-quarter financial results.
Alignment Healthcare’s Valuation Shows Promise In A Competitive Market: Analyst
Alignment Healthcare Inc (NASDAQ: ALHC) announced that its California Medicare Advantage (MA) HMO – which represents roughly 89% of its MA membership – has maintained an overall 4 out of 5-star rating from the Centers for Medicare & Medicaid Services (CMS) for 2024, marking its seventh
Obesity Medication Insurance Coverage? Employers Embrace the Inclusion of Novo Nordisk’s Wegovy in Health Coverage
Coverage for obesity medications, including Novo Nordisk A/S's (NYSE: NVO) Wegovy, is expected to expand among U.S.
Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Gainers
Orchard Therapeutics plc (NASDAQ: ORTX) shares climbed 97.7% to $15.98 after the company agreed to be acquired by Japan's Kyowa Kirin for $16.00 per ADS in cash plus an additional contingent value right of $1.00 per ADS.
